These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 894100)

  • 1. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipyrine excretion and aminopyrine breath test: use and significance in the assessment of liver function].
    Gugler R
    Z Gastroenterol; 1987 Mar; 25 Suppl 2():51-6. PubMed ID: 3590907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
    Kuntz HD; Meessen D; May B
    Med Welt; 1982 Jun; 33(25):909-10. PubMed ID: 7109938
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
    Sonnenberg A; Koelz HR; Herz R; Benes I; Blum AL
    Hepatogastroenterology; 1980 Apr; 27(2):104-8. PubMed ID: 6783497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of physical stress on the disposition of drugs eliminated by the liver in man.
    Swartz RD; Sidell FR; Cucinell SA
    J Pharmacol Exp Ther; 1974 Jan; 188(1):1-7. PubMed ID: 4809269
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
    Branch RA; James JA; Read AE
    Gut; 1974 Oct; 15(10):837-8. PubMed ID: 4434964
    [No Abstract]   [Full Text] [Related]  

  • 12. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic relevance of the aminopyrine breath test in liver disease].
    Wildgrube HJ; Stang H
    Z Gastroenterol; 1982 Nov; 20(11):667-72. PubMed ID: 7180067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the elimination of drugs during labor].
    Nöschel H; Müller B; Tröltzsch M; Bonow A
    Zentralbl Gynakol; 1974 Jan; 96(4):118-22. PubMed ID: 4411002
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Drug metabolism in disease.
    Hepner GW
    Lancet; 1974 May; 1(7865):1048-9. PubMed ID: 4133721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.